Cortisol: The villain in metabolic syndrome?

Revista da Associacao Medica Brasileira

Volumn 60, Issue 1, 2014, Pages 84-92

  Paredes, Sílvia ^a   Ribeiro, Laura ^a,b  

^a University of Porto   (Portugal)

^b Institute of Pharmacology and Therapeutics   (Portugal)

Author keywords

11 Hydroxysteroid; Dehydrogenase; Glucocorticoids; Insulin resistance; Metabolic syndrome; Obesity; Stress

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADIPOCYTOKINE; ADIPONECTIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTISONE; GLUCOCORTICOID; GLUCOCORTICOID ANTAGONIST; HYDROCORTISONE; INSULIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; VASOPRESSIN;

ARTICLE; CHRONIC STRESS; CLINICAL FEATURE; CUSHING SYNDROME; CYTOKINE RELEASE; DISEASE ASSOCIATION; FOOD INTAKE; HUMAN; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; INTRAPERITONEAL FAT; LIPID STORAGE; MENTAL STRESS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; COMPLICATION; INTRAABDOMINAL FAT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; DIABETES MELLITUS, TYPE 2; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; METABOLIC SYNDROME X; OBESITY; STRESS, PHYSIOLOGICAL;

EID: 84927173219     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/1806-9282.60.01.017     Document Type: Article

References (53)

1. Kyrou I, Tsigos C. Stress hormones: physiological stress and regulation of metabolism. Curr Opin Pharmacol. 2009;9:787-93.
2. Pasquali R, Vicennati V, Cacciari M, Pagotto U. The hypothalamic-pituitaryadrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci. 2006;1083:111-28.
3. Kyrou I, Chrousos G, Tsigos C. Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci. 2006;1083:77-110.
4. McWwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998;840:33-44.
5. Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, et al. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoidactivating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene. Mol Cell Endocrinol. 2008;285:10-8.
6. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293:1861-7.
7. Shomali M. Diabetes treatment in 2025: can scientific advances keep pace with prevalence? Ther Adv Endocrinol Metab. 2012;3:163-73.
8. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation. 2002;106:2659-65.
9. Vicennati V, Pasqui F, Cavazza C, Pagotto U, Pasquali R. Stress-related development of obesity and cortisol in women. Obesity. 2009;17:1678-83.
10. Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ. 2006;332:521-5.
11. Rosmond R, Dallman MF, Björntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab. 1998;83:1853-9.
12. Charmandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Annu Rev Physiol. 2005;67:259-84.
13. Vegiopoulos A, Herzig S. Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol. 2007;275:43-61.
14. Wang M. The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome. Nutr Metab (Lond). 2005;2:3.
15. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53:865-71.
16. Torpy DJ, Ho JT. Corticosteroid-binding globulin gene polymorphisms: clinical implications and links to idiopathic chronic fatigue disorders. Clin Endocrinol (Oxf). 2007;67:161-7.
17. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009;94:2692-701.
18. Wamil M, Seckl JR. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target. Drug Discov Today. 2007;12:504-20.
19. Walker BR, Andrew R. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann N Y Acad Sci. 2006;1083:165-84.
20. Walker BR. Extra-adrenal regeneration of glucocorticoids by 11betahydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning. Proc Nutr Soc. 2007;66:1-8.
21. Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology. 2005;30:1-10.
22. Brown ES. Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann N Y Acad Sci. 2009;1179:41-55.
23. Fiuza M, Cortez-Dias N, Martins S, Belo A. Síndrome metabólica em Portugal: Prevalência e implicações no risco cardiovascular: resultados do Estudo Valsim. Rev Port Cardiol. 2008;27:1495-529.
24. Shively CA, Register TC, Clarkson TB. Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation. Am J Primatol. 2009;71:742-51.
25. Ribeiro Filho FF, Mariosa LS, Ferreira SR, Zanella MT. Gordura visceral e síndrome metabólica: mais que uma simples associação. Arq Bras Endocrinol Metab. 2006;50:230-8.
26. Haun D, Pitanga F, Lessa I. Razão cintura/estatura comparado a outros indicadores antropométricos de obesidade como preditor de risco coronariano elevado. Rev Assoc Med Bras. 2009;55:705-11.
27. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med. 2005;56:45-62.
28. Shively CA, Laber-Laird K, Anton RF. Behavior and physiology of social stress and depression in female cynomolgus monkeys. Biol Psychiatry. 1997;41:871-82.
29. Pereira CD, Azevedo I, Monteiro R, Martins MJ. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus. Diabetes Obes Metab. 2012;14:869-81.
30. Rask E, Walker B, Söderberg S, Livingstone DE, Eliasson M, Johnson O, et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab. 2002;87:3330-6.
31. Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH. Cortisol metabolism in human obesity: impaired cortisone->cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab. 1999;84:1022-7.
32. Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DE, Johnson O, et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab. 2001;86:1418-21.
33. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21:697-738.
34. Peckett AJ, Wright DC, Riddell MC. The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism. 2011;60:1500-10.
35. Espíndola-Antunes D, Kater CE. Adipose tissue expression of 11betahydroxysteroid dehydrogenase type 1 in Cushing's syndrome and in obesity. Arq Bras Endocrinol Metab. 2007;51:1397-403.
36. Christ-Crain M, Kola B, Lolli F, Fekete C, Seboek D, Wittmann G, et al. AMPactivated protein kinase mediates glucocorticoid induced metabolic changes: a novel mechanism in Cushing's syndrome. FASEB. J 2008;22:1672-83.
37. Walker BR. Cortisol - cause or cure for metabolic syndrome? Diabet Med. 2006;23:1281-8.
38. Joharapurkar A, Dhanesha N, Shah G, Kharul R, Jain M. 11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome. Pharmacol Rep. 2012;64:1055-65.
39. Costa J, Duarte J. Tecido adiposo e citocinas. Acta Med Port. 2006;19:251-6.
40. Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U, et al. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J. 1997;321:707-12.
41. Ikeoka D, Madjer J, Pieber T. Adipose tissue, inflammation and cardiovascular disease. Rev Assoc Med Bras. 2010;56:116-21.
42. Vasseur F, Meyre D, Froguel P. Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies. Expert Rev Mol Med. 2006;20:1-12.
43. Hermsdorff HH, Monteiro JB. Gordura visceral, subcutânea ou intramuscular: onde está o problema? Arq Bras Endocrinol Metab. 2004;48:803-11.
44. Nieuwenhuizen AG, Rutters F. The hypothalamic-pituitary-adrenal-axis in the regulation of energy balance. Physiol Behav. 2008;94:169-77.
45. Warne JP. Shaping the stress response: Interplay of palatable food choices, glucocorticoids, insulin and abdominal obesity. Mol Cell Endocrinol. 2009;300:137-46.
46. Adam TC, Epel ES. Stress, eating and the reward system. Physiol Behav. 2007;91:449-58.
47. Seckl JR, Morton NM, Chapman KE, Walker BR. Glucocorticoids and 11betahydroxysteroid dehydrogenase in adipose tissue. Recent Prog Horm Res. 2004;59:359-93.
48. Wajchenberg BL, Nery M, Cunha MR, Silva ME. Adipose tissue at the crossroads in the development of the metabolic syndrome, inflammation and atherosclerosis. Arq Bras Endocrinol Metab. 2009;53:145-50.
49. Sakamuri VP, Ananthathmakula P, Veettil GN, Ayyalasomayajula V. Vitamin A decreases pre-receptor amplification of glucocorticoids in obesity: study on the effect of vitamin A on 11beta-hydroxysteroid dehydrogenase type 1 activity in liver and visceral fat of WNIN/Ob obese rats. Nutr J. 2011;10:70.
50. Al-Daghri N, Alkharfy K, Al-Saleh Y, Al-Attas O, Alokail M, Al-Othman A, et al. Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism. 2012;61:661-6.
51. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005;28:2926-32.
52. Azevedo A, Santos A, Ribeiro L, Azevedo I. The metabolic syndrome. In: Soares R, Costa C, editors. Oxidative stress, inflammation and angiogenesis in the metabolic syndrome. Netherlands: Springer; 2009. p.1-19
53. Monteiro R, Castro P, Calhau C, Azevedo I. Adipocyte size and liability to cell death. Obes Surg. 2006;16:804-6.